drugset

drugset / Trial / NCT00154778

Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer

NCT00154778 ↗

Phase 2 Completed 55 enrolled National Taiwan University Hospital Mackay Memorial Hospital · collab National Cheng-Kung University Hospital · collab National Health Research Institutes, Taiwan · collab Taipei Veterans General Hospital, Taiwan · collab Tri-Service General Hospital (TSGH) · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the response rate of Paclitaxel combination chemotherapy with UFT and Leucovorin in patients with advanced gastric cancer.

Timeline

Start: 2003-03
Primary completion: —
Completion: 2005-06

Publications

Results Chao Y, Li CP, Chao TY, Su WC, Hsieh RK, Wu MF, Yeh KH, Kao WY, Chen LT, Cheng AL. An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer. Br J Cancer. 2006 Jul 17;95(2):159-63. doi: 10.1038/sj.bjc.6603225. Epub 2006 Jun 27.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Leucovorin	Small molecule	90 mg	—
Subject	Paclitaxel	Small molecule	100 mg/m2	Intravenous
Subject	UFT	Unknown	300 mg/m2	Oral

Indications